Asabys Partners

What they do

Founded in 2018 by Josep Ll. Sanfeliu and Clara Campàs, Asabys Partners is a specialized life sciences venture capital firm backed by Alantra and Banco Sabadell. The firm focuses on pushing the boundaries of science and medicine by backing disruptive health technologies across Europe and globally. In October 2025, Asabys strategically integrated Aliath Bioventures, significantly expanding its platform and positioning itself as one of the largest life sciences GPs in Southern Europe. The firm is highly regarded for its hands-on approach, frequently co-founding or providing pre-seed capital to spin-offs from top Spanish research institutes.

What they look for

Asabys Partners invests in highly innovative and disruptive companies covering unmet medical needs in the biopharma, medical device, and digital health verticals. Their core strategy is to fund solutions built on solid scientific evidence that provide a clear, transformative benefit for patients. The firm explicitly looks for breakthrough science, robust clinical validation, scalable platforms, and strong multidisciplinary teams. They are highly active in tech transfer and company creation, frequently backing spin-offs from major research centers, and seek technologies with the potential to become first-in-class or best-in-class treatments.

Stage

Pre-seed, Seed, Series A, Series B+

Sectors

Healthcare

Based

Barcelona, ES